NCT01537029View on ClinicalTrials.gov

Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide

PHASE4CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Breast CancerObesity
Interventions
DRUG

Doxorubicin

Dosed by the patient's treating physician according to local standard of care.

DRUG

Cyclophosphamide

dosage form: IV, Dosage, frequency, and duration: According to local standard of care

Trial Locations (1)

75390

University of Texas Southwestern, Dallas

All Listed Sponsors
collaborator

University of Texas

OTHER

lead

Texas Tech University Health Sciences Center

OTHER

NCT01537029 - Effect of Weight on the Population Pharmacokinetic Analysis of Doxorubicin and Cyclophosphamide | Biotech Hunter | Biotech Hunter